Semler Scientific Investor Relations Material

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company offers QuantaFlo, a peripheral artery disease testing tool that enables clinicians to deliver additional tests and treatment options; Predictiv, a blood draw collection device, which streamlines the blood draw process for licensed practitioners with the use of proprietary micro-sampling technology; and MediTrack solution to enable patients to track their medications on a mobile device. It also develops award-winning testing methods for plaque identification in weaker arteries; and technology for automatic detection and identification of individual components of blood flow to aid in diagnosing peripheral vascular disease and other ailments. Semler Scientific, Inc. was founded in 2006 and is based in Portland, Oregon.